Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYTHS-MR: Methylprednisolone in Acute Myocarditis
NCT05974462Phase 3Recruiting
- Start
- May 2024
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of methylprednisolone in acute myocarditis. Started May 2024; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
acute myocarditis
Beyond the preview
Go deeper on NCT05974462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05974462.